Philip R. Debruyne

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

Benoit Beuselinck, Pascal Wolter, Alexandra Karadimou et al. · British Journal of Cancer · 2012 · 110 citations · Full text

Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life

Lies Pottel, Michelle Lycke, Tom Boterberg et al. · European Journal of Cancer Care · 2014 · 96 citations

Bile Acids Induce Ectopic Expression of Intestinal Guanylyl Cyclase C Through Nuclear Factor-κB and Cdx2 in Human Esophageal Cells

Philip R. Debruyne, Matthew E. Witek, Li Gong et al. · Gastroenterology · 2006 · 90 citations · Full text

G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy

Lies Pottel, Michelle Lycke, Tom Boterberg et al. · BMC Cancer · 2015 · 85 citations · Full text

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Advanced Ovarian Cancer, Medicine, Pharmacology +9